Lam Research Corporation (LRCX) Stock: Price, Forecast & Analyst Target
Lam Research Corporation (LRCX) — MoonshotScore 91/100 (Exceptional band), calculated Nov 18, 2026. Price $211.67 (+0.47%), as of the Nov 18, 2026 trading session; market cap $264B. Expected results Jan 27, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 35.50× (cash as of Sep 27, 2026) · expected results Jan 27, 2027
Lam Research Corporation · LRCX · NASDAQ · Technology · Semiconductors
Research dated 2026-09-12: Lam Research sells the deposition, etch, cleaning and metrology equipment that semiconductor manufacturers use inside wafer fabrication, then supports that installed base through repair and maintenance. The decisive question is whether expanding fabrication spending and adoption of platforms such as Akara can sustain growth in systems and support strongly enough to meet the expectations embedded in the valuation.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · Lam Research (LRCX)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality, a strong balance sheet and elite growth, but an expensive valuation. Business Quality: Elite; Financial Safety: Fortress; Valuation: Rich; Growth Durability: Compounding; Momentum: Quiet.
Price relative to book value is the main valuation drag relative to sector peers.
- EPS beat 0 of the last 4 reports
- expected results Jan 27, 2027
- Altman Z 17.46 · Piotroski F 7
Holding back: a rich price
Helping: business quality, balance-sheet strength, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 89 | Exceptional | |
| 89 | Exceptional | |
| 89 | Exceptional | |
| 89 | Exceptional | |
| 91 | Exceptional | |
| 91 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $211.67 | |
| Change on the day | +0.47% | |
| 52-week range | $135.50–$438.50 | |
| Market capitalisation | $264B | — |
| Price / earnings (trailing) | 31.21 | |
| Shares traded on the day | 7.61M | |
| Beta (volatility vs the S&P 500) | 2.01 | |
| Dividends per share (last 12 months) | $1.11 | |
| Dividend yield (last 12 months) | 0.53% |
Why Lam Research scores 91
Share price, last 12 months +33.0%
$166.37 $221.31
What the price assumes
17.2% a year of free-cash-flow growth for ten years is what a $276.45B market value ( snapshot) asks for.
The price already assumes faster growth than the last 5 years delivered. Anything short of an acceleration leaves room to disappoint. It also runs ahead of the analysts' revenue path.
Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $6.54B. Inputs: FMP statements, estimates and quote.
How the stock reacts to earnings
EPS beat in 10 of the last 12 reports (2024–2026); the stock still fell the next session after 2 of those beats. Average first-session move: 5.6% either way.
- +4.2%Jan ’24
- +1.6%Apr ’24
- -2.9%Jul ’24
- +4.9%Oct ’24
- +8.3%Jan ’25
- +11.7%Apr ’25
- -4.1%Jul ’25
- +1.7%Oct ’25
- +4.1%Jan ’26
- +0.1%Apr ’26
- +10.4%Jul ’26
- -12.6%Oct ’26
Every report, with revenue and five-session moves
| Report | EPS | Revenue | Next session | 5 sessions |
|---|---|---|---|---|
| In line | In line | -12.6% | -3.7% | |
| Beat | In line | +10.4% | +14.0% | |
| Beat | Beat | +0.1% | -3.7% | |
| Beat | Beat | +4.1% | -12.0% | |
| Beat | Beat | +1.7% | +10.8% | |
| Beat | Beat | -4.1% | -3.0% | |
| Beat | Beat | +11.7% | +12.9% | |
| Beat | Beat | +8.3% | +10.0% | |
| Beat | Beat | +4.9% | +4.7% | |
| Beat | Beat | -2.9% | -12.5% | |
| Miss | Beat | +1.6% | -2.2% | |
| Beat | Beat | +4.2% | -0.6% |
Beats have usually been rewarded — 8 of 10 drew a higher close the next session.
What management is saying differently
Management's own words on the Q1 FY2027 call () against Q4 FY2026 (). Analysts' questions are left out.
- New this call: “wafer capacity”, “backside power”, “advanced patterning”, “slc class” — none of them came up in Q4 FY2026.
- Getting louder: “advanced packaging” (5 → 12 mentions), “etch intensity” (1 → 5 mentions).
- Gone quiet: “plus layer”, “upside bias” — regular themes last call, absent this time.
- Tone: Cautious words such as “may”, “could” and “headwind” fell from 4.1 to 2.8 per 1,000 words, and confident words such as “record” and “strong” fell from 5.2 to 3.1.
Management sounded more assured than a quarter earlier — fewer hedging words, more of the confident kind.
Our track record on this stock
Since the score went from 93 to 91 while the share price moved -31.8% through .
The score has stayed in the Exceptional band across the stretch we have recorded; we grade each band change three months after it happens.
The crowd against our signals
- Analysts: 78% of 50 rate it a buy; the average target sits +79.7% from the price of $211.67.
- Last 90 days: 11 rating actions, every one a reaffirmation.
- Our signals: Exceptional band; strongest pillar Business Quality (96), weakest Valuation (30).
Here we and the crowd agree. Where we differ is on price: our Valuation reading is more cautious than the analysts' targets.
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Events are in date order; the spacing is not a duration scale. Estimated dates can change.
Other perspectives
Council score for Lam Research (LRCX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
3 lenses, 3 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Lam Research (LRCX), and what does it report?
Short answer · as of
Lam is not selling semiconductors; it is selling the equipment that enables their manufacture.
Research dated 2026-09-12.
Its portfolio covers film deposition, conductor and dielectric etch, wafer cleaning, bevel treatment and in-line mass measurement, with demand tied to fabrication investment and the process requirements of integrated circuits.
Reported revenue separates new systems from customer support and other activity. That distinction matters because the results measure both equipment placements and the repair, maintenance and related work attached to Lam's installed base across major semiconductor-producing regions.
What do the latest results show for Lam Research (LRCX)?
Research dated 2026-09-12.
The latest reported period extended a broad expansion: revenue, gross profit, operating profit, net income and diluted earnings all advanced from the preceding period and reached the strongest levels in the displayed quarterly series. Annual revenue and net income also moved well above the preceding annual periods, while research spending continued to rise.
Every earnings release in the displayed history exceeded the associated revenue and earnings estimates. Separately, management raised its view of industry wafer-fab-equipment spending, described continued expansion of the Akara installed base and said a large-format panel tool would ship into the advanced-packaging transition; those statements outline the proposed growth mechanism rather than prove future demand.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $8.22B Sep 27, 2026
- Latest quarter · R&D
- $666.40M Sep 27, 2026
- Latest quarter · SG&A
- $348.73M Sep 27, 2026
- Latest quarter · FMP standardized operating result
- $3.28B Sep 27, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 27, 2026 | $8.22B | $666.40M | $348.73M | $3.28B |
| Jun 28, 2026 | $6.72B | $642.92M | $322.33M | $2.51B |
| Mar 29, 2026 | $5.84B | $583.20M | $280.31M | $2.05B |
| Dec 28, 2025 | $5.34B | $573.30M | $267.65M | $1.81B |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $8.22B Oct 21, 2026
- Latest report · revenue estimate
- $8.14B Oct 21, 2026
- Latest report · revenue vs estimate
- Above estimate Oct 21, 2026
- Latest report · EPS vs estimate
- Above estimate Oct 21, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Oct 21, 2026 | $8.22B | $8.14B | $2.2000 | $2.1800 |
| Jul 29, 2026 | $6.72B | $6.66B | $1.8200 | $1.6900 |
| Apr 22, 2026 | $5.84B | $5.75B | $1.4700 | $1.3600 |
| Jan 28, 2026 | $5.34B | $5.23B | $1.2700 | $1.1700 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $5.32B | $1.57B | $1.24 (diluted) |
| Q2 FY2026 | $5.34B | $1.59B | $1.26 (diluted) |
| Q3 FY2026 | $5.84B | $1.83B | $1.45 (diluted) |
| Q4 FY2026 | $6.72B | $2.28B | $1.81 (diluted) |
What are the financial strengths and risks for Lam Research (LRCX)?
Short answer
Cash and short-term investments were $7.44B at the Sep 27, 2026 balance-sheet date. Operating cash flow was $3.50B for the quarter ended Sep 27, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-12.
Lam generates substantial operating cash flow, holds more cash and investments than debt, and reports ample short-term liquidity. Its profitability and financial-quality screens also point to a business entering the next reporting cycle from a strong operating and balance-sheet position.
The cushion should not be confused with valuation support. Cash finished below the opening level of the displayed history, recent capital spending increased sharply, and the market value places far more weight on future earnings than on the current free-cash-flow yield. A retreat in wafer-fab-equipment budgets would strike the larger systems revenue line directly, leaving the support business to absorb only part of the pressure.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $3.50B Sep 27, 2026
- Previous quarter · operating cash flow
- $1.46B Jun 28, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Sep 27, 2026 | $3.50B | −$257.70M |
| Jun 28, 2026 | $1.46B | −$188.80M |
| Mar 29, 2026 | $1.14B | −$331.60M |
| Dec 28, 2025 | $1.48B | −$260.88M |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at Lam Research (LRCX)?
Short answer · as of
The next earnings report is expected on Jan 27, 2027.
Research dated 2026-09-12.
The next report should show whether the recent sequential acceleration is continuing and whether revenue and earnings again clear market expectations. Within that result, watch systems against customer support, gross and operating profit conversion, operating cash flow after heavier capital spending, and the cash balance.
Operationally, Akara adoption and the panel-tool shipment are the most concrete tests of management's growth narrative. Tax expense also deserves attention because management expects revenue in higher-tax jurisdictions, particularly the United States, to raise the effective rate. Longer-range estimates assume continued expansion but spread widely, making execution more informative than the consensus headline.
How does Lam Research compare with its peers?
Short answer
Lam Research's score ranks tied for 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Within semiconductor equipment, Lam's disclosed breadth reaches across deposition, multiple etch applications, cleaning, bevel treatment and wafer metrology. That gives it exposure to several process steps inside a fabrication plant, while the separately reported customer-support business adds revenue tied to equipment already operating in the field.
The useful comparison is therefore not with a chip designer whose economics depend on selling finished devices. Lam's demand unit is a fabrication tool placement and the work that follows around the installed base, so customer capital budgets, manufacturing complexity and tool adoption matter more directly than the selling price of any particular chip.
| Company | Price | Market value | Score |
|---|---|---|---|
| $705.27 Nov 18, 2026 | $798B | 99 5-pillar Nov 18, 2026 | |
| $292.43 Nov 18, 2026 | $267B | 92 5-pillar Nov 18, 2026 | |
| $354.05 Nov 18, 2026 | $1.69T | 92 5-pillar Nov 18, 2026 | |
| Lam Research (LRCX) — this page | $211.67 | $264B | 91 |
| $1395.27 Nov 18, 2026 | $538B | 91 5-pillar Nov 18, 2026 | |
| $144.88 Nov 18, 2026 | $189B | 86 5-pillar Nov 18, 2026 | |
| $381.98 Nov 18, 2026 | $185B | 83 5-pillar Nov 18, 2026 | |
| $530.14 Nov 18, 2026 | $877B | 82 5-pillar Nov 18, 2026 | |
| $1310.91 Nov 18, 2026 | $63.9B | 82 5-pillar Nov 18, 2026 | |
| $352.30 Nov 18, 2026 | $280B | 81 5-pillar Nov 18, 2026 | |
| $32.53 Nov 18, 2026 | $71.8B | 77 5-pillar Nov 18, 2026 | |
| $252.47 Nov 18, 2026 | $63.6B | 77 5-pillar Nov 18, 2026 | |
| $159.81 Nov 18, 2026 | $171B | 76 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $290.00 – $500.00
- Consensus target
- $379.25
- Median target
- $367.50
Consensus record · Captured .
Measured against a quoted price of $211.67 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Nov 10, 2026
- Transactions
- 60
- Identified insiders
- 12
- Purchases
- 0
- Sales
- 35
- Other transactions
- 25
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 84.2% Period end Sep 30, 2026
- Previous quarter · ownership
- 86.2% Prior to period end Sep 30, 2026
- Reporting holders
- 3,072 Period end Sep 30, 2026
- Previous quarter · holders
- 3,259 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 132,321,368 |
| Vanguard Capital Management LLC | 81,906,956 |
| State Street Corp | 60,295,789 |
| Invesco Ltd. | 50,616,248 |
| Jpmorgan Chase & Co | 45,941,312 |
Tracked investors
Which of the 16 named investors we follow held LRCX in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Coatue | Philippe Laffont | Q3 2026 | 5.98% | $3.26B | Added +5.1% shares |
| Tiger Global | Chase Coleman | Q3 2026 | 3.57% | $720.53M | Trimmed −30.7% shares |
| Appaloosa | David Tepper | Q3 2026 | 2.72% | $205.32M | Added +63.4% shares |
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 1.51% | $348.18M | Added +13.0% shares |
| Duquesne Family Office | Stanley Druckenmiller | Q3 2026 | 0% | $0 | Sold out (was $18.89M) |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Lam Research Technology Stock: Key Questions Answered
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does Akara adoption mean for Lam Research?
Akara is an etch platform whose installed base has expanded sharply since launch, according to management. Continued adoption would support the claim that Lam is gaining equipment placements, while subsequent support activity could broaden the economic contribution.
How do Flex and Kiyo fit into Lam Research's business?
Flex addresses dielectric etch applications, while Kiyo handles conductor etch processes. Together they show that Lam participates in distinct fabrication steps rather than selling a generic semiconductor machine.
Why does Customer Support and Other matter for Lam Research?
The line captures economic activity beyond new system sales, including repair and ongoing maintenance around deployed equipment. It gives Lam a business linked to the installed base as well as current fabrication-equipment purchases.
What would Lam Research's panel-tool shipment demonstrate?
The shipment would demonstrate that Lam has equipment positioned for a large-format advanced-packaging transition. It would not by itself establish broad customer adoption, so later placements and their contribution to systems revenue remain the meaningful checks.
What is the LRCX stock price today?
The last price recorded for Lam Research Corporation (LRCX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the LRCX price target?
The analyst consensus price target for Lam Research Corporation (LRCX), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Reviewed by Sedat ANAK, Founder and Editor-in-Chief, on 2026-11-07.
Sources: the source register lists the 81 figures on this page — 1 from SEC filings and earnings calls, 70 from Financial Modeling Prep (FMP), 3 with no recorded source, 5 computed by us, formula shown in the register and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold LRCX
Funds in our ETF coverage that list LRCX among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
